Buying Esperion Therapeutics Despite An Abiding Skepticism Weighing On The Stock (ESPR)
Ariel Skelley/DigitalVision through Getty Pictures President and CEO of Esperion Therapeutics, Inc. (NASDAQ:ESPR), Sheldon Koenig, promised that the corporate would ...
